Citations

Mayo Clinic

Showing 10 of 108572 citations.

Novel Medications for the Irritable Bowel Syndrome: Motility and Sensation
Camilleri, Michael

Journal of Pediatric Gastroenterology and Nutrition | February 7, 2024 | Volume: 32 | Issue: S1 | Pages: No page available

10.1002/j.1536-4801.2001.tb07345.x Get It

Coexistence of Celiac Disease and Eosinophilic Gastroenteropathy
Rosenthal, Eldad, Bentur, Lea , Gleich, Gerald J. , Naveh, Yehezkel, Amirav, Israel

Journal of Pediatric Gastroenterology and Nutrition | February 7, 2024 | Volume: 33 | Issue: 2 | Pages: 200-201

10.1002/j.1536-4801.2001.tb07437.x Get It

Commentary on A Differential Diagnosis of Thrombotic Microangiopathy in a 7-Year-Old Girl
Moyer, Ann M.

Clinical Chemistry | February 7, 2024 | Volume: 70 | Issue: 2 | Pages: 373-373

10.1093/clinchem/hvad213 | PMID 38321878 Get It

Home Parenteral Nutrition in Chronic Intestinal Diseases
Amarnath, R. P., Fleming, C. Richard, Perrault, Jean, Fleming, C. Richard

Journal of Pediatric Gastroenterology and Nutrition | February 7, 2024 | Volume: 6 | Issue: 1 | Pages: 89-95

10.1002/j.1536-4801.1987.tb09250.x Get It

SummaryNine children and adolescents with chronic intestinal diseases and growth failure were treated with home parenteral nutrition (HPN) for 7–63 months. All patients improved their growth velocities on HPN, with an average height gain of 9 cm. The mean growth velocity in six patients with Crohn's disease increased more than fivefold (from 0.67 ± 0.4 cm/year to 3.8 ± 1.09 cm/year), and they gained a mean of 11.4 ± 3.4 kg/year. The three patients without Crohn's disease [intestinal pseudo‐obstruction (two), severe short bowel (one)] increased growth velocity from an average of 2.9 ± 1.1 cm to 6.1 ± 1.34 cm/year and gained a mean of 10 ± 2.84 kg/year. Patients without Crohn's disease grew faster on HPN than age comparable patients with Crohn's disease. Also, the two patients with Crohn's disease who were younger and had their disease for a shorter period (<3 years) grew better than older patients with Crohn's disease who had their disease for a mean of 8 ± 1.3 years. All patients improved clinically, and three with Crohn's disease achieved complete remission. Five of the nine patients had psychosocial adjustment problems while on HPN. In conclusion, HPN is a relatively safe and effective means to stimulate growth in children and adolescents who cannot meet nutritional needs by the enteral route.
EARLY EPITHELIAL ALTERATIONS IN "LATENT/AT RISK" CELIAC PATIENTS WITH NORMAL HISTOLOGY
Saha, Kamalika, Kistner, Emily O., Guandalini, Stefano , Jabrì, Bana , Setty, Mala , Turner, Jerrold R. , Bhagat, Govind , Murray, Joseph A. , Jabrì, Bana

Journal of Pediatric Gastroenterology and Nutrition | February 7, 2024 | Volume: 43 | Issue: 4 | Pages: No page available

10.1002/j.1536-4801.2006.tb13840.x Get It

Effect of age on in‐hospital outcomes of transvenous lead extraction for infected cardiac implantable electronic device
Tan, Min Choon , Ang, Qi Xuan , Yeo, Yong Hao , Thong, Jia Yean, Tolat, Aneesh , Scott, Luis R. , Lee, Justin Z. , Yeo, Yong Hao , Tan, Min C

Pacing and Clinical Electrophysiology | February 7, 2024 | Volume: 47 | Issue: 4 | Pages: 577-582

10.1111/pace.14939 | PMID 38319639 Get It

AbstractBackgroundThe real‐world data on the safety profile of transvenous lead extraction (TLE) for infected cardiac implantable electronic devices (CIED) among elderly patients is not well‐established. This study aimed to evaluate the hospital outcomes between patients of different age groups who underwent TLE for infected CIED.MethodUsing the Nationwide Readmissions Database, our study included patients aged ≥18 years who underwent TLE for infected CIED between 2017 and 2020. We divided the patients into four groups: Group A. Young (<50 years), Group B. Young intermediate (50–69 years old), Group C. Older intermediate (70–79 years old), and Group D. Octogenarian (≥80 years old). We then analyzed the in‐hospital outcome and 30‐day readmission between these age groups.ResultsA total of 10,928 patients who were admitted for TLE of infected CIED were included in this study: 982 (9.0%) patients in group A, 4,234 (38.7%) patients in group B, 3,204 (29.3%) patients in group C and 2,508 (23.0%) of patients in group D. Our study demonstrated that the risk of early mortality increased with older age (Group B vs. Group A: OR: 1.92, 95% CI: 1.19‐3.09, p < .01; Group C vs. Group A: OR: 2.47, 95% CI: 1.51‐4.04, p < .01; Group D vs. Group A: OR: 2.82, 95% CI: 1.69‐4.72, p < .01). The risk of non‐home discharge also increased in elderly groups (Group B vs. Group A: OR: 1.89; 95% CI: 1.52‐2.36; p < .01; Group C vs. Group A: OR: 2.82; 95% CI 2.24‐3.56; p < .01; Group D vs. Group A: OR: 4.16; 95% CI: 3.28‐5.28; p < .01). There was no significant difference in hospitalization length and 30‐day readmission between different age groups. Apart from a higher rate of open heart surgery in group A, the procedural complications were comparable between these age groups.ConclusionElderly patients had worse in‐hospital outcomes in early mortality and non‐home discharge following the TLE for infected CIED. There was no significant difference between elderly and non‐elderly groups in prolonged hospital stay and 30‐day readmission. Elderly patients did not have a higher risk of procedural complications.
Impact of age on hospital outcomes after catheter ablation for ventricular tachycardia
Tan, Min Choon , Yeo, Yong Hao , Ang, Qi Xuan , Kiwan, Chrystina, Fatunde, Olubadewa A. , Lee, Justin Z. , Tolat, Aneesh , Sorajja, Dan , Fatunde, Olubadewa, Yeo, Yong Hao , Tan, Min C

Journal of Arrhythmia | February 7, 2024 | Volume: 40 | Issue: 2 | Pages: 317-324

10.1002/joa3.12998 | PMID 38586842 Get It

AbstractBackgroundThe real‐world data on the safety profile of ventricular tachycardia (VT) ablation among elderly patients is not well‐established. This study aimed to evaluate the procedural outcomes among those aged 18–64 years versus those aged ≥65 years who underwent catheter ablation of VT.MethodUsing the Nationwide Readmissions Database, our study included patients aged ≥18 years who underwent VT catheter ablation between 2017 and 2020. We divided the patients into non‐elderly (18–64 years old) and elderly age groups (≥65 years old). We then analyzed the in‐hospital procedural outcome and 30‐day readmission between these two groups.ResultsOur study included 2075 (49.1%) non‐elderly patients and 2153 (50.9%) elderly patients who underwent VT ablation. Post‐procedurally, elderly patients had significantly higher rates of prolonged index hospitalization (≥7 days; 35.5% vs. 29.3%, p < .01), non‐home discharge (13.4% vs. 6.0%, p < .01), 30‐day readmission (17.0% vs. 11.4%, p < .01), and early mortality (5.5% vs. 2.4%, p < .01). There was no significant difference in the procedural complications between two groups, namely vascular complications, hemopericardium/cardiac tamponade, cerebrovascular accident (CVA), major bleeding requiring blood transfusion, and systemic embolization. Through multivariable analysis, the elderly group was associated with higher odds of early mortality (OR: 7.50; CI 1.86–30.31, p = .01), non‐home discharge (OR: 2.41; CI: 1.93–3.00, p < .01) and 30‐day readmission (OR: 1.58; CI 1.32–1.89, p < .01).ConclusionElderly patients have worse in‐hospital outcome, early mortality, non‐home discharge, and 30‐day readmission following catheter ablation for VT. There was no significant difference between elderly and non‐elderly groups in the procedural complications.
Navigating breast health: a comprehensive approach to atypical ductal hyperplasia of the breast management and surveillance
Islam, N. , Vegunta, Suneela , Islam, Nadia

Exploration of Medicine | February 7, 2024 | Volume: 5 | Issue: 1 | Pages: 59-64

10.37349/emed.2024.00205 Get It

Atypical ductal hyperplasia (ADH) is a benign lesion of the breast that is associated with an increased risk of invasive breast cancer. This review explores the pathophysiology, risk factors for progression to breast cancer, and lifetime management for patients diagnosed with ADH on core needle biopsy (CNB). The management plan for patients diagnosed with ADH includes regular clinical surveillance, diagnostic mammography, along with risk-reduction strategies such as lifestyle modifications or the use of adjuvant endocrine therapies. This review aims to delve into the complexities of ADH from diagnosis to management to aid clinicians in finding the best way to approach this high-risk breast lesion.
Technical note: Generalizable and promptable artificial intelligence model to augment clinical delineation in radiation oncology
Liu, Zhengliang , Zhang, Lu , Feng, Hongying , Dai, Haixing , Li, Xiang , Wong, William W. , Vora, Sujay A., Liu, Tianming , Zhang, Lian , Wu, Zihao , Yu, Xiaowei , Holmes, Jason , Li, Quanzheng , Zhu, Dajiang , Liu, Wei , Li, Xiang

Medical Physics | February 7, 2024 | Volume: 51 | Issue: 3 | Pages: 2187-2199

10.1002/mp.16965 | PMID 38319676 Get It

Abstract Background Efficient and accurate delineation of organs at risk (OARs) is a critical procedure for treatment planning and dose evaluation. Deep learning‐based auto‐segmentation of OARs has shown promising results and is increasingly being used in radiation therapy. However, existing deep learning‐based auto‐segmentation approaches face two challenges in clinical practice: generalizability and human‐AI interaction. A generalizable and promptable auto‐segmentation model, which segments OARs of multiple disease sites simultaneously and supports on‐the‐fly human‐AI interaction, can significantly enhance the efficiency of radiation therapy treatment planning. Purpose Meta's segment anything model (SAM) was proposed as a generalizable and promptable model for next‐generation natural image segmentation. We further evaluated the performance of SAM in radiotherapy segmentation. Methods Computed tomography (CT) images of clinical cases from four disease sites at our institute were collected: prostate, lung, gastrointestinal, and head & neck. For each case, we selected the OARs important in radiotherapy treatment planning. We then compared both the Dice coefficients and Jaccard indices derived from three distinct methods: manual delineation (ground truth), automatic segmentation using SAM's ’segment anything’ mode, and automatic segmentation using SAM's ‘box prompt’ mode that implements manual interaction via live prompts during segmentation. Results Our results indicate that SAM's segment anything mode can achieve clinically acceptable segmentation results in most OARs with Dice scores higher than 0.7. SAM's box prompt mode further improves Dice scores by 0.1∼0.5. Similar results were observed for Jaccard indices. The results show that SAM performs better for prostate and lung, but worse for gastrointestinal and head & neck. When considering the size of organs and the distinctiveness of their boundaries, SAM shows better performance for large organs with distinct boundaries, such as lung and liver, and worse for smaller organs with less distinct boundaries, like parotid and cochlea. Conclusions Our results demonstrate SAM's robust generalizability with consistent accuracy in automatic segmentation for radiotherapy. Furthermore, the advanced box‐prompt method enables the users to augment auto‐segmentation interactively and dynamically, leading to patient‐specific auto‐segmentation in radiation therapy. SAM's generalizability across different disease sites and different modalities makes it feasible to develop a generic auto‐segmentation model in radiotherapy.
Cellular Enhancement of Frozen Meniscus Allograft Combining Native Meniscus and Mesenchymal Stromal Cell Injections
Struijk, Caroline , Lydon, Katherine L. , Husen, Martin , Michielsen, Jozef , Wijnen, André J. van , Krych, Aaron J. , Saris, Daniël B.F. , Krych, Aaron J , van Wijnen, Andre J , Verdonk, Peter

CARTILAGE | February 7, 2024 | Volume: 16 | Issue: 4 | Pages: 475-485

10.1177/19476035231224802 | PMID 38321966 Get It

Objective This proof-of-concept study investigated an improved cell-based injection therapy combining mesenchymal stem cells (MSCs) and meniscus cells (MCs) to support superior meniscus allograft repopulation and early revival compared to injecting MSCs alone. Design In this controlled laboratory study, frozen meniscus allograft samples were injected vertically with a cell suspension containing different ratios of MSCs and MCs or control (lactated ringers) and cultured for 28 days. Samples were analyzed weekly for cell viability, migration, and metabolism using histological and biochemical assays. Tissue medium was analyzed for matrix metalloproteinase (MMP) expression using zymography. Results Cellular repopulation of frozen allografts injected with different cell suspensions was validated by immunohistochemistry. Significant higher DNA content was evidenced in grafts treated with suspensions of MCs or MC:MSC (1:4 ratio). Cell metabolic activity was significantly different between all treated groups and control group after 1 week. Allografts injected with MCs showed significantly more cell proliferation than injections with MSCs. MMP2 activity was detected in medium of all grafts cellularized with MCs with or without MSCs. Scanning electron microscopy (SEM) analysis showed resolution of the needle puncture, but not in the control group. Cell labeling of MCs upon injection of mixed MC:MSC suspensions revealed a gradual increase in the cell ratio. Conclusions The findings of this study establish that injection of MCs with or without MSCs enhances the cellularity of meniscus allograft to support early graft revival and remodeling.